ArticleInvesting In Canadian Intellectual Property – The Federal CommitmentOn April 19th, 2021, the Canadian Federal government tabled its first budget since the last federal election.CanadaIntellectual PropertySmart & Biggar
ArticleLicensing Of COVID-19 Diagnostic IP To Facilitate Fast Access In The Third WorldThe World Health Organization (WHO) and the Medicines Patent Pool (MPP) secured a license from the Spanish National Research Council (CSIC; Consejo Superior de Investigaciones Científicas) ...CanadaIntellectual PropertySmart & Biggar
ArticleNew 2021 Tax Deduction For Intellectual Property Protected Innovations In QuébecOn March 10, 2020, the Government of Québec announced an incentive tax deduction for the commercialization of innovations ...CanadaIntellectual PropertySmart & Biggar
ArticleNew Trademarks Act Amendments In Government's USMCA Implementing LegislationOn May 29, 2019, the Canadian Government introduced Bill C-100, legislation designed to meet obligations included in the United States-Mexico-Canada Agreement (USMCA).CanadaIntellectual PropertySmart & Biggar
ArticleOntario Government Unveils Intellectual Property Action Plan Along With COVID-19 Research ProjectsLast year, the Ontario government convened an Expert Panel on Intellectual Property, chaired by Jim Balsillie. He has long advocated for publicly funded research and other institutions to take a...CanadaIntellectual PropertySmart & Biggar
ArticlePre-Amended PMNOC Regulations: Court Decisions On The Merits (Polymorph, Salt, Formulation Patents)There have been two Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) decisions on the merits so far in 2019 and a pair of appeal decisionsCanadaIntellectual PropertySmart & Biggar
ArticleSupreme Court Of Canada Reserves Decision On Appeal Relating To The Patentability Of Methods Of Medical TreatmentOver ten years have passed since the Federal Court of Appeal (FCA) flagged the patentability of methods of medical treatment as being worthy of full consideration by the Supreme Court of Canada. This issue has finally come before the Court.CanadaIntellectual PropertySmart & Biggar
ArticleSupreme Court Of Canada Takes A Pass On Patented Drug Price DisputeThe Board decision was quashed, and the case was sent back to the Board for redetermination. CanadaIntellectual PropertySmart & Biggar
ArticleSupreme Court Of Canada To Hear York University/Access Copyright AppealsOn October 15, 2020, the Supreme Court of Canada granted applications brought by both York University and Access Copyright for leave to appeal the Federal Court ...CanadaIntellectual PropertySmart & Biggar
ArticleUSPTO: AI Cannot Be Named As Inventor On PatentOn April 27, 2020, the United States Patent and Trademark Office published a petition decision stating that under current law...CanadaIntellectual PropertySmart & Biggar
ArticleClass Actions Relating To Opioid Use Disorder Continue Across CanadaThere are multiple ongoing class actions in Canada against pharmaceutical companies related to Opioid Use Disorder (OUD) and its effects. While these proceedings are all currently in their early stages...CanadaLitigation, Mediation & ArbitrationSmart & Biggar
ArticleFederal Court Of Appeal Dismisses Appeal Of First Trial Decision Under The Amended PMNOC RegulationsAny appeal by Amgen would require the grant of leave by the Supreme Court of Canada.CanadaLitigation, Mediation & ArbitrationSmart & Biggar
ArticleNew Court Proceedings (May 2022)Taro Pharmaceuticals v Biogen and Acorda Therapeutics.CanadaLitigation, Mediation & ArbitrationSmart & Biggar
ArticleFederal Enforcement Agencies Remind Canadian Mobile App Companies Of Their CASL ObligationsCanada's Anti-Spam Legislation (CASL) is enforced by three federal agencies, the Canadian Radio-television and Telecommunications Commission (CRTC)...CanadaMedia, Telecoms, IT, EntertainmentSmart & Biggar
ArticleHandling Patient Data In Artificial IntelligenceThere has been a vast expansion in the use of AI in healthcare. There are many privacy issues that accompany unlocking the potential of AI.CanadaPrivacySmart & Biggar
ArticleMisleading Privacy Claims Results In $9 Million Dollar Penalty For FacebookOn May 19, 2020 the Competition Bureau announced that as part of a registered settlement, Facebook Inc. will pay a $9 million penalty plus an additional $500,000 for the costs of the Bureau's investigation.CanadaPrivacySmart & Biggar
ArticleBrexit's Impact On Canadian Owners Of EU TrademarksOn January 29, 2020, the European Union (EU) Parliament approved the Brexit Withdrawal Agreement to officially end the UK's...GlobalIntellectual PropertySmart & Biggar
ArticleCIPO Extends Industrial Design Protection To Buildings And StructuresThe Industrial Design Office has announced that it is changing its practice with respect to industrial designs applied to buildings or structures.GlobalIntellectual PropertySmart & Biggar
ArticleProtecting AI-Created Works - US Seeking Comments On Copyright. What About Canada?The U.S. Patent and Trademark Office is seeking comments on what the impact would be on providing copyright protection to works created using artificial intelligence,GlobalIntellectual PropertySmart & Biggar